JUN 25, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Piroxicam (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for piroxicam labeling changes; does not contain clinical trial data or efficacy evidence.
Reported
Approval status date2026-06-25
Application numberANDA206136
Strengths approved10 mg and 20 mg capsules